Establishment Labs Holdings (ESTA) EBITDA Margin Growth (3y) (2020 - 2026)
Establishment Labs Holdings (ESTA) EBITDA Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 244.00 |
| 10 | Establishment Labs Holdings | 2.16 Bn | 2.09 Bn | 47.71 Mn | 2,189.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,189.00 |
| Mar 31, 2026 | 667.00 |
| Dec 31, 2025 | 2,395.00 |
| Sep 30, 2025 | 2,002.00 |
| Jun 30, 2025 | -224.00 |
| Mar 31, 2025 | -2,646.00 |
| Dec 31, 2024 | -1,542.00 |
| Sep 30, 2024 | -152.00 |
| Jun 30, 2024 | -670.00 |
| Mar 31, 2024 | -1,686.00 |
| Dec 31, 2023 | -4,034.00 |
| Sep 30, 2023 | -4,325.00 |
| Jun 30, 2023 | 6,345.00 |
| Mar 31, 2023 | 1,393.00 |
| Dec 31, 2022 | -1,187.00 |
| Sep 30, 2022 | 1,085.00 |
| Jun 30, 2022 | 1,801.00 |
| Mar 31, 2022 | 2,587.00 |
| Dec 31, 2021 | 2,605.00 |
| Sep 30, 2021 | 598.00 |